Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Jonathan Arnold1, Deeksha Acharya2, Hetal Boricha2
1Department of Medicine, University of Pittsburgh School of Medicine, USA.

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
07:59Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
PubMed で要約を見る
脂質低下療法 (LLT) は,動脈硬化性心血管疾患 (ASCVD) の予防に不可欠です. しかし,実際のデータでは,多くの患者がガイドラインで推奨されている高強度スタチン療法を受けていないことが示され,ASCVDのリスク軽減戦略の改善の必要性を示しています.
科学分野:
背景:
研究 の 目的:
主な方法:
主要な成果:
結論: